Account-creators
1,040
edits
Difference between revisions of "Neurodegenerative diseases"
Jump to navigation
Jump to search
Neurodegenerative diseases (view source)
Revision as of 06:46, 24 October 2019
, 06:46, 24 October 2019→Clinical perspective: Poor clinical - molecular correlations
Jensflorian (talk | contribs) (→Molecular: Update) |
Jensflorian (talk | contribs) (→Clinical perspective: Poor clinical - molecular correlations) |
||
| Line 200: | Line 200: | ||
=Clinical perspective= | =Clinical perspective= | ||
*Correlations between clinical signs and molecular can be poor. | |||
**Example: The MAPT A152T gene mutation in the MAPT gene may cause clinical symptoms matching AD, [[Neurodegenerative diseases#Corticobasal degeneration|CBD]], [[Neurodegenerative diseases#Progressive supranuclear palys|PSP]] and [[Neurodegenerative diseases#Lewy body disease|LBD]]. | |||
===Dementia general (mostly useless) DDx=== | ===Dementia general (mostly useless) DDx=== | ||
*[[Alzheimer's disease|Alzheimer's]] dementia - most common. | *[[Alzheimer's disease|Alzheimer's]] dementia - most common. | ||